SHINE Selects Baker Concrete Construction

2017-11-16T12:23:33+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has chosen Baker Concrete Construction, Inc. (Baker) to be the prime contractor for the construction of its medical isotope production facility in Janesville, Wisconsin.  In conjunction, Brad Wucherpfennig, President of Baker, has joined the SHINE board of directors.

SHINE Selects Baker Concrete Construction 2017-11-16T12:23:33+00:00

Miltenberger Promoted to Chief of Staff

2017-08-24T15:24:42+00:00

August 24, 2017  – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Steve Miltenberger has been promoted to Chief of Staff. The announcement comes as the company prepares to build its facility in Janesville, Wisconsin, […]

Miltenberger Promoted to Chief of Staff 2017-08-24T15:24:42+00:00

Grand Opening of new SHINE Global HQ

2017-08-01T08:31:03+00:00

January 16, 2017 - SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a ribbon cutting ceremony to celebrate the grand opening of the company’s new global headquarters in downtown Janesville, Wisconsin. The ribbon cutting was led by the John Beckord and the Forward Janesville Goodwill Ambassadors.

Grand Opening of new SHINE Global HQ 2017-08-01T08:31:03+00:00

SHINE Awarded $20.9M DOE/NNSA Phase II

2017-08-01T08:35:37+00:00

December 12, 2016 - SHINE Medical Technologies announced today that it has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement.

SHINE Awarded $20.9M DOE/NNSA Phase II 2017-08-01T08:35:37+00:00

HTA and SHINE Sign Mo-99 Supply Agreement

2017-09-20T14:06:00+00:00

June 21, 2016 - HTA Co., Ltd. (HTA), the largest Chinese producer and distributor of radio-pharmaceuticals, and SHINE Medical Technologies (SHINE), a U.S. company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the companies have entered into a strategic agreement for the supply of molybdenum-99 (moly-99).

HTA and SHINE Sign Mo-99 Supply Agreement 2017-09-20T14:06:00+00:00

SHINE Holds 2nd 2015 Community Meeting

2017-08-01T08:40:34+00:00

December 7, 2015 - SHINE invites the Janesville community to an update on the development of its medical isotope production facility. Since our last meeting in June, SHINE’s primary regulator, the Nuclear Regulatory Commission, has completed their safety and environmental reviews and recommended the approval of a Construction Permit for the SHINE facility.

SHINE Holds 2nd 2015 Community Meeting 2017-08-01T08:40:34+00:00